Matthew Shea
Stock Analyst at Needham
(0.94)
# 4,031
Out of 5,149 analysts
3
Total ratings
33.33%
Success rate
-1.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $15 → $4 | $3.51 | +13.96% | 1 | Feb 25, 2026 | |
| ASTH Astrana Health | Initiates: Buy | $28 | $24.51 | +14.24% | 1 | Dec 12, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $5 | $2.70 | +85.19% | 1 | Nov 25, 2025 |
Evolent Health
Feb 25, 2026
Maintains: Buy
Price Target: $15 → $4
Current: $3.51
Upside: +13.96%
Astrana Health
Dec 12, 2025
Initiates: Buy
Price Target: $28
Current: $24.51
Upside: +14.24%
The Oncology Institute
Nov 25, 2025
Initiates: Buy
Price Target: $5
Current: $2.70
Upside: +85.19%